The law firm of Kessler Topaz Meltzer & Check, LLP (  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQ: XRAY) on behalf of ...

Jefferies Financial Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a buy rating to a hold rating ...

NEW YORK, NY / ACCESS Newswire / January 25, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to ...

RADNOR, PA / ACCESS Newswire / January 25, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP( informs investors that ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.53 which represents a slight increase of $0.09 or 0.46% from the prior close of $19.44. The stock opened at $19.41 and ...

The Portnoy Law Firm advises Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) investors of a class action representing investors that bought securities between February 28, 2022, and ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.44 which represents a slight increase of $0.08 or 0.41% from the prior close of $19.36. The stock opened at $19.19 and ...

Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") of a class action securities ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ...

Fintel reports that on January 23, 2025, Jefferies downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from Buy to Hold. Analyst Price Forecast Suggests 21.99% Upside As of December 23, 2024, ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares faced a downgrade in stock rating by Jefferies from Buy to Hold, with a significant reduction in the price target to $20.00 from the previous $30.00. The firm ...

The global dental matrix systems market is on track for substantial expansion, with forecasts predicting a significant ...